Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Eccleston

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Nature Reviews. Drug Discovery|August 25, 2022
RNA structure guides antiviral ASO designAlex Eccleston
Nature Reviews. Drug Discovery|August 25, 2023
Clipping cell-surface mucins in cancer by targeted degradationAlex Eccleston
Nature Reviews. Drug Discovery|March 10, 2026
Synthetic lethal strategy targets p53-deficient cancersAlex Eccleston
Nature Reviews. Drug Discovery|July 31, 2023
Peptide vaccine turns up the heat in ALK-positive cancersAlex Eccleston
Nature Reviews. Drug Discovery|July 1, 2022
Targeting cancers with chromosome instabilityAlex Eccleston
Nature Reviews. Drug Discovery|March 25, 2025
Cannabinoid targets hidden pocket for safer pain reliefAlex Eccleston
Nature Reviews. Drug Discovery|September 27, 2023
Rewired proteostasis in KRAS inhibitor resistanceAlex Eccleston
Nature Reviews. Drug Discovery|February 5, 2025
Peptide blocks phase separation and oncogenic transcriptionAlex Eccleston
Nature Reviews. Drug Discovery|October 29, 2025
Lectin-based bispecific targets tumour-associated glycansAlex Eccleston
Nature Reviews. Drug Discovery|December 2, 2025
Omics with active learning optimizes phenotypic screensAlex Eccleston
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Nature Reviews. Drug Discovery|August 25, 2022
RNA structure guides antiviral ASO designAlex Eccleston
Nature Reviews. Drug Discovery|August 25, 2023
Clipping cell-surface mucins in cancer by targeted degradationAlex Eccleston
Nature Reviews. Drug Discovery|March 10, 2026
Synthetic lethal strategy targets p53-deficient cancersAlex Eccleston
Nature Reviews. Drug Discovery|July 31, 2023
Peptide vaccine turns up the heat in ALK-positive cancersAlex Eccleston
Nature Reviews. Drug Discovery|July 1, 2022
Targeting cancers with chromosome instabilityAlex Eccleston
Nature Reviews. Drug Discovery|March 25, 2025
Cannabinoid targets hidden pocket for safer pain reliefAlex Eccleston
Nature Reviews. Drug Discovery|September 27, 2023
Rewired proteostasis in KRAS inhibitor resistanceAlex Eccleston
Nature Reviews. Drug Discovery|February 5, 2025
Peptide blocks phase separation and oncogenic transcriptionAlex Eccleston
Nature Reviews. Drug Discovery|October 29, 2025
Lectin-based bispecific targets tumour-associated glycansAlex Eccleston
Nature Reviews. Drug Discovery|December 2, 2025
Omics with active learning optimizes phenotypic screensAlex Eccleston
Pageof 6